1. Induction of arachidonate 12-lipoxygenase mRNA by epidermal growth factor in A431 cells.
- Author
-
Chang WC, Liu YW, Ning CC, Suzuki H, Yoshimoto T, and Yamamoto S
- Subjects
- Antibodies, Monoclonal immunology, Antibody Specificity, Arachidonic Acid metabolism, Blood Platelets enzymology, Blotting, Northern, Cycloheximide pharmacology, DNA Probes, Humans, Immunosorbent Techniques, Linoleic Acid, Linoleic Acids metabolism, Microsomes enzymology, Substrate Specificity, Tumor Cells, Cultured, Arachidonate 12-Lipoxygenase genetics, Epidermal Growth Factor pharmacology, RNA, Messenger biosynthesis
- Abstract
12(S)-Hydroxyeicosatetraenoic acid is biosynthesized from arachidonic acid by the microsomal fraction of human epidermoid carcinoma A431 cells, and the microsomal 12-lipoxygenase activity is enhanced by about 2-fold by epidermal growth factor (EGF) with a 10-h lag period (Chang, W.C., Ning, C.C., Lin, M.T., and Huang, J.D. (1992) J. Biol. Chem. 267, 3657-3666). The microsomal 12-lipoxygenase in A431 cells was only 3% active with linoleic acid as compared with arachidonic acid. The enzyme was immunoprecipitated by a monoclonal antibody against human platelet 12-lipoxygenase but not by that against porcine leukocyte enzyme. A 3.1-kilobase mRNA was detected in A431 cells by Northern blot analyses using cDNA probe of human platelet 12-lipoxygenase. EGF could increase the 12-lipoxygenase mRNA level by about 2-fold with a lag period of 10 h, which was well parallel with the increase in the enzyme activity. The induction of the 12-lipoxygenase mRNA by EGF was completely blocked by 35 microM cycloheximide, if present in culture medium during EGF treatment, indicating that a de novo protein biosynthesis was essential for EGF-induced 12-lipoxygenase mRNA expression. Our data provide the first evidence for the inducibility of human 12-lipoxygenase gene expression by a growth factor.
- Published
- 1993